Universal admission laboratory screening for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) asymptomatic infection across a large health system.

Cihlar, Jennifer L; Harris, Bryan D; Wright, Patty W; Humphries, Romney M; Taylor, Caroline K; Cherry, Brandi R; Talbot, Thomas R

Cihlar, Jennifer L; Harris, Bryan D; Wright, Patty W; Humphries, Romney M; Taylor, Caroline K; Cherry, Brandi R; Talbot, Thomas R.

Affiliation

Cihlar JL; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.
Harris BD; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.
Wright PW; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.
Humphries RM; Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee.
Taylor CK; Department of Enterprise Analytics, Vanderbilt University School of Medicine, Nashville, Tennessee.
Cherry BR; Department of Enterprise Analytics, Vanderbilt University School of Medicine, Nashville, Tennessee.
Talbot TR; Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee.

Infect Control Hosp Epidemiol ; 44(1): 68-74, 2023 01.

Article in En | MEDLINE | ID: mdl-36533305

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic_studies / Prognostic_studies / Screening_studies Limits: Humans Language: En Journal: Infect Control Hosp Epidemiol Journal subject: DOENCAS TRANSMISSIVEIS / ENFERMAGEM / EPIDEMIOLOGIA / HOSPITAIS Year: 2023 Document type: Article Country of publication:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google